Literature DB >> 3923935

A novel proteolytic activity in serum processes rat prohaptoglobin.

J M Hanley, E C Heath.   

Abstract

The heterotetrameric plasma glycoprotein rat haptoglobin previously was shown to be synthesized by hepatocytes in a precursor form, prohaptoglobin, which contains one alpha-subunit region and one beta-subunit region. Two of these molecules, each with a molecular weight of 45,000, are joined by a disulfide bond and subsequently the subunit regions of each polypeptide are separated by site-specific proteolysis, yielding the tetrameric native protein. Although some of this processing occurs intracellularly, a substantial proportion of the prohaptoglobin is secreted [J. M. Hanley, T. H. Haugen, and E. C. Heath (1983) J. Biol. Chem. 258, 7858-7869]. However, a proteolytic activity was found in rat plasma and serum which also is capable of site-specific cleavage of prohaptoglobin. Further investigation of this novel activity has demonstrated that it cleaves prohaptoglobin accurately, in the same site-specific manner as the intracellular protease, and that it most likely is not a serine protease or a metalloenzyme but can be inhibited by sulfhydryl-reactive compounds. Furthermore, it appears to be synthesized and secreted by hepatocytes, and thus may be identical to the intracellular processing protease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923935     DOI: 10.1016/0003-9861(85)90706-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein.

Authors:  Krzysztof B Wicher; Erik Fries
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-22       Impact factor: 11.205

2.  Proteolytic cleavage of haptoglobin occurs in a subcompartment of the endoplasmic reticulum: evidence from membrane fusion in vitro.

Authors:  M Wassler; E Fries
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

3.  Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

Authors:  Mi-Kyung Oh; Hansol Joo; In-Sook Kim
Journal:  PLoS One       Date:  2022-05-17       Impact factor: 3.240

4.  An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia.

Authors:  Yasmin Ahmad; Narendra K Sharma; Iti Garg; Mohammad Faiz Ahmad; Manish Sharma; Kalpana Bhargava
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

5.  Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.

Authors:  N Ahmed; G Barker; K T Oliva; P Hoffmann; C Riley; S Reeve; A I Smith; B E Kemp; M A Quinn; G E Rice
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

6.  Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy.

Authors:  Aik-Aun Tan; Alan Kang-Wai Mu; Lik-Voon Kiew; Yeng Chen
Journal:  Cancer Cell Int       Date:  2014-11-30       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.